Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.72 |
| ▸ | NPY2R | P49146 | 1/20 | 0.72 |
| ▸ | NPY4R | P50391 | 1/20 | 0.72 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.53 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.51 |
| ▸ | FURIN | P09958 | 1/20 | 0.51 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31151641 | 0.98 | NPY1R (0.69) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL30114882 | 0.98 | NPY1R (0.69) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL30361827 | 0.96 | NPY4R (0.67) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL31151720 | 0.94 | NPY4R (0.65) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL31151549 | 0.93 | NPY1R (0.64) | NPY1RNPY2RNPY4R | |
| SCHEMBL31151562 | 0.93 | NPY1R (0.64) | NPY1RNPY2RNPY4R | |
| SCHEMBL30361862 | 0.92 | NPY1R (0.65) | NPY1RNPY2RNPY4R | |
| SCHEMBL30361983 | 0.90 | NPY1R (0.67) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL29961427 | 0.89 | NPY1R (0.74) | NPY1RNPY2RNPY4RNTSR2NTSR1 | |
| SCHEMBL29501591 | 0.89 | NPY4R (0.83) | NPY1RNPY2RNPY4ROPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713002-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | Forssmann, Wolf-Georg (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4501347-A1 | PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501348-A1 | PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024235986-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | PHARIS BIOTEC GMBH (DE) | 2024-11-21 | — | — | WO | disclosed |